Çetın Ordu
- Oncology top 10%
- Cancer Risks and Factors 6
- Cancer Treatment and Pharmacology 6
- Cancer survivorship and care 5
- Lymphatic System and Diseases 4
- Cancer Research top 10%
- Breast Cancer Treatment Studies 17
- Pathology and Forensic Medicine top 10%
- Breast Lesions and Carcinomas 5
- Orthopedics and Sports Medicine top 10%
-
- Family Support in Illness 5
-
- Radiomics and Machine Learning in Medical Imaging 4
- Co-authors
- Kezban Nur PilancıGül AlçoVahit ÖzmenFiliz AğaçayakFiliz ÇelebiZeynep ErdoğanFatma AktepeAhmet Serkan İlgün
- Journals
- Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (7 papers)PLoS ONE (1 paper)
- Partner nations
- TürkiyeUnited StatesIndia
In The Last Decade
Çetın Ordu
56 papers receiving 701 citations
Peers
Comparison fields: 5 of 86
- Oncology 395
- Cancer Research 190
- Pathology and Forensic Medicine 117
- Internal Medicine 20
- Orthopedics and Sports Medicine 44
Countries citing papers authored by Çetın Ordu
This map shows the geographic impact of Çetın Ordu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Çetın Ordu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Çetın Ordu more than expected).
Fields of papers citing papers by Çetın Ordu
This network shows the impact of papers produced by Çetın Ordu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Çetın Ordu. The network helps show where Çetın Ordu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Çetın Ordu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 12 | |
| 8 | 2019 | 2 | |
| 9 | 2018 | 23 | |
| 10 | 2018 | 3 | |
| 11 | 2018 | 42 | |
| 12 | Receptor discordance rate and its effects on survival in primary and recurrent breast cancer patients. | 2017 | 13 |
| 13 | 2015 | 18 | |
| 14 | 2015 | 29 | |
| 15 | 2015 | 23 | |
| 16 | 2014 | 5 | |
| 17 | 2014 | 31 | |
| 18 | 2013 | 12 | |
| 19 | 2011 | 10 | |
| 20 | 2011 | 8 |
About Çetın Ordu
Çetın Ordu is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 61 papers that have together received 708 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (17 papers), Cancer Risks and Factors (6 papers), Cancer Treatment and Pharmacology (6 papers), Family Support in Illness (5 papers), Cancer survivorship and care (5 papers), Breast Lesions and Carcinomas (5 papers), Lymphatic System and Diseases (4 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). The work is most often cited by research in Oncology (395 citations), Cancer Research (190 citations) and Pathology and Forensic Medicine (117 citations). Çetın Ordu has collaborated with scholars based in Türkiye, United States and India. Frequent co-authors include Kezban Nur Pilancı, Gül Alço, Vahit Özmen, Filiz Ağaçayak, Filiz Çelebi, Zeynep Erdoğan, Fatma Aktepe, Ahmet Serkan İlgün, Özgür Tanrıverdi and Yeşim Eralp. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.